Uri Weinberg - 05 Jan 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Science Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Uri Weinberg
Issuer symbol
NVCR
Transactions as of
05 Jan 2023
Net transactions value
-$854,216
Form type
4
Filing time
09 Jan 2023, 17:24:06 UTC
Previous filing
07 Jul 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale $285,480 -2,379 -4.8% $120.00 47,104 05 Jan 2023 Direct F1
transaction NVCR Ordinary Shares Options Exercise $91,540 +1,946 +4.1% $47.04 49,050 05 Jan 2023 Direct F1
transaction NVCR Ordinary Shares Sale $233,520 -1,946 -4% $120.00 47,104 05 Jan 2023 Direct F1
transaction NVCR Ordinary Shares Sale $282,636 -2,617 -5.6% $108.00 44,487 05 Jan 2023 Direct F1
transaction NVCR Ordinary Shares Sale $144,120 -1,201 -2.7% $120.00 43,286 05 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -1,946 -50% $0.000000 1,946 05 Jan 2023 Ordinary Shares 1,946 $47.04 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.
F2 Fully vested as of the date hereof.